Technology

Google Ad

Sypris continues to establish itself in the space race. by winning a contract for deep space program electronic assemblies for power management and other Systems. The spacecraft is designed to serve as the exploration vehicle that will carry the crew to space, provide emergency abort capability, sustain missions and provide safe re-entry from deep space return velocities.

GM unveiled the production version of the Cadillac Lyriq, its first all-electric vehicle as the automaker confirmed that every new Cadillac vehicle will be all-electric starting now. Cadillac brand should be all-electric a little bit ahead of the rest of General Motors target of electric only by 2035.

Biopharmaceutical company MacroGenics Announced Wednesday FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer following Phase 3 clinical trials. Product launch anticipated in March of 2021

The European Commission announced the Digital Services and Digital Markets Acts in their battle to reign in the control and influence of tech giants who could face hefty fines up to 10% of annual global revenue for non-compliance and breakups. In the sights are social media platforms and online market places.

Moderna reported that it's phase one results show that experimental vaccine for COVID-19 is safe and induces an immune response in it's early stage study. $MRNA Shares surged 16% on the news.

AstraZeneca on Thursday announced rresults of a clinical trial of its genetically targeted lung cancer drug Tagrisso with an “overwhelming benefit”. $AZN said after two years 89% of the lung cancer patients given Tagrisso following surgery were alive without a recurrence of their tumors.

Co-Diagnostics stock has reversed after surging ahead of it's first-quarter earnings Thursday and up date of it's Coronavirus test. $CODX had hit multiple all time highs ahead of the reports.

Allogene Therapeutics on Wednesday released data on the success of it's off-the-shelf CAR-T cell therapy for an aggressive form of B-cell lymphoma blood cancer. The results showing some patients experienced complete remission. The stock $ALLO surged over 50% on the release.

Gilead Sciences’ antiviral medicine remdesivir is showing positive results in a closely watched clinical trial in Chicago. While early days warrants cautions, there have been rapid recoveries in fever and respiratory symptoms. $GILD stock jumped 14.4% on the latest results.

The Bejing medical briefing in China on Wednesday addressed many concerns that have caused panic in the world. They said no data is showing virus incubation of longer than 14 days and the median incubation period lasts 5-7 days.

Google ads